文献速递肿瘤 PET/CT神经核医学

生长抑素受体PET/CT中交感神经节生理性摄取:患病率、模式与生物学依据

Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-06-24

该回顾性研究分析101例患者[18F]AlF-NOTA-LM3 PET/CT,发现76.2%存在交感神经节摄取,呈双侧对称分布且摄取低于转移淋巴结(SUVmax 2.29±0.67 vs 14.52±14.29,P<0.001),SUVmax阈值3.45鉴别准确率95.9%,免疫组化证实神经节神经元SSTR2表达。

要点

  • 交感神经节摄取常见(76.2%),多呈双侧对称、低摄取。
  • SUVmax阈值3.45可高精度区分神经节与转移淋巴结。
  • 神经节神经元SSTR2表达为摄取提供生物学依据。

核心结论

  • 交感神经节在SSTR PET/CT上的摄取是常见生理性表现,特征为对称分布和低摄取。
  • 神经节神经元SSTR2阳性表达是这种摄取的生物学基础。

研究设计与样本

  • 回顾性分析101例患者的[18F]AlF-NOTA-LM3 PET/CT图像,评估交感神经节摄取。
  • 结合临床数据和正常器官摄取分析影响因素,并比较神经节与转移淋巴结的摄取模式。
  • 对星状神经节等标本行SSTR2免疫组化染色。

主要发现

  • 76.2%(77/101)患者存在交感神经节阳性摄取。
  • 星状、胸部、腹腔和骶部神经节阳性率分别为76.2%(77/101)、33.7%(34/101)、23.8%(24/101)、32.7%(33/101)。
  • 交感神经节摄取与较高的垂体、肾上腺、小肠摄取及较低肿瘤负荷相关。
  • 交感神经节摄取一般呈双侧对称分布,且显著低于淋巴结转移(SUVmax:2.29 ± 0.67 vs. 14.52 ± 14.29;P < 0.001)。
  • SUVmax阈值3.45区分交感神经节与转移淋巴结的准确率为95.9%,AUC为0.967。

关键数值与推荐

  • 交感神经节摄取与转移淋巴结鉴别的SUVmax阈值为3.45,准确率95.9%,AUC 0.967。
  • 免疫组化显示部分星状神经节神经元胞膜和胞质及十二指肠肌间和黏膜下丛神经元SSTR2中等表达。

临床怎么用

  • 判读SSTR PET/CT时需识别交感神经节对称性低摄取的生理模式,避免误判为转移。
  • 对疑似神经节摄取灶可参考SUVmax 3.45阈值辅助鉴别转移淋巴结。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to investigate the prevalence, pattern, physiological basis, and influencing factors of sympathetic ganglia uptake on [18F]AlF-NOTA-LM3 PET/CT. METHODS: [18F]AlF-NOTA-LM3 PET/CT images from 101 patients were retrospectively reviewed to evaluate the presence of sympathetic ganglia uptake. Clinical data and normal-organ uptake were investigated to identify influencing factors. Uptake patterns were compared between sympathetic ganglia and metastatic lymph nodes. Immunohistochemical (IHC) staining for SSTR2 was performed on a stellate ganglion and other specimens. RESULTS: Positive sympathetic ganglia were observed in 76.2% (77/101) of patients on [18F]AlF-NOTA-LM3 PET/CT. 76.2% (77/101), 33.7% (34/101), 23.8% (24/101), 32.7% (33/101) of patients exhibited positive stellate, thoracic, celiac, and sacral ganglia, respectively. Sympathetic ganglia uptake was associated with higher pituitary, adrenal gland, small-intestinal uptake, and lower tumor burden. Sympathetic ganglia generally exhibited a bilateral symmetric distribution and significantly lower uptake than lymph node metastases (SUVmax: 2.29 ± 0.67 vs. 14.52 ± 14.29; P < 0.001). An SUVmax cutoff of 3.45 differentiated sympathetic ganglia from metastatic lymph nodes with an accuracy of 95.9% and an AUC of 0.967. IHC revealed moderate SSTR2 expression in the membrane and cytoplasm of a subset of stellate ganglionic neurons and in neurons of both the myenteric and submucosal plexuses of duodenum. CONCLUSION: Sympathetic ganglia uptake on SSTR PET/CT is a common physiological finding, featured by symmetric distribution and faint uptake. Histopathology confirming SSTR2-positive ganglionic neurons provides the biological basis for this uptake.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Liu M, Hong R, Zhang Y, et al. Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale. Eur J Nucl Med Mol Imaging. 2026. PMID: 42340391. doi:10.1007/s00259-026-08021-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。